PDLIM7 and lymphoproliferative syndrome: This is in agreement with earlier data showing that EBV-strains, encoding for this LMP-1 peptide variant were also a risk factor for the development of EBV+ post-transplant lymphoproliferative disorders (EBV+PTLD) (16).